Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

WHO Alert Spurs India's Probe Into Deadly Cough Syrup, Licence Cancelled, 700 Plus Units Audited, Parliament Informed

Susmita Roy6 Dec 2025 11:22 PM IST

New Delhi: In response to the World Health Organization's alert of 13 October 2025 on contaminated cough syrups linked to child deaths, the Union...

CDSCO Panel Seeks Protocol Revisions in Levim Lifetech's Teriparatide Biosimilar Study

Susmita Roy6 Dec 2025 11:02 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has opined that LevimLifetech revise the...

Drug, Vaccine Lab Tests May Cost Up to Rs 45,000 with 5% Annual Hike

Same Brand Name Used for Multiple Drugs: Govt Panel Calls for Stakeholder Consultation

Susmita Roy6 Dec 2025 10:51 PM IST

New Delhi: In a move aimed at addressing growing concerns over brand name extensions in the pharmaceutical sector, the Drugs Consultative Committee...

Abuse of the Process of Law: Delhi HC Upholds Dismissal of Complaint Against Hospital, Doctor Accused of Medical Negligence

Semaglutide Patent Clash: Delhi HC Denies Novo Nordisk Injunction, Manufacturing by Dr Reddy's to Continue

Susmita Roy5 Dec 2025 10:28 PM IST

New Delhi: In a significant development in the high-stakes patent litigation over diabetes blockbuster Semaglutide, the Delhi High Court has refused...

Govt Panel Approves Inclusion of Emergency Contraceptive Levonorgestrel Under Schedule K

Susmita Roy4 Dec 2025 9:52 PM IST

New Delhi: In a move aimed at streamlining regulatory clarity and improving access to essential reproductive health products, the Drugs Consultative...

CDSCO Panel Denies Trial Waiver for Atropine, Asks Sun Pharma to Conduct Phase III Study

Susmita Roy4 Dec 2025 8:57 PM IST

New Delhi: Rejecting the proposal for a clinical trial waiver for Atropine Sulphate Ophthalmic Solution IP 0.025% w/v, the Subject Expert Committee...

CDSCO Launches Online Risk Classification Module for Non-IVD Medical Devices

CDSCO Issues Risk Classification List for 187 Interventional Radiology Devices, Details

Susmita Roy3 Dec 2025 5:31 PM IST

New Delhi: In a move to streamline regulatory oversight of medical devices, the Central Drugs Standard Control Organisation (CDSCO) has released the...

Alkem Gets CDSCO Panel Nod to Market Synthetic Semaglutide Injection in Multiple Strengths for Type 2 Diabetes

Susmita Roy2 Dec 2025 10:22 PM IST

New Delhi: Alkem Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control...

NPPA Notifies New MRP for Key Cardiac, Diabetes and Antibiotic Drugs, Details

Susmita Roy2 Dec 2025 9:38 PM IST

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...

PEPFIX-NEOVITAL Row: Delhi HC Says Sun Pharma's Suit Maintainable, Cites Online Presence

Susmita Roy1 Dec 2025 5:35 PM IST

New Delhi: The Delhi High Court has refused to return a trademark infringement suit filed by Sun Pharmaceutical Industries against Artura...

Pharmacist's Job Requires Mobility: HP High Court Rejects Orthopedically Disabled Candidate's Claim for Appointment

Susmita Roy30 Nov 2025 4:30 PM IST

Shimla: The Himachal Pradesh High Court has dismissed a writ petition filed by Sajil Kumar, an orthopedically disabled candidate who sought quashing...

Akums Drugs Secures EU-GMP Certification for Two Haridwar Plants

CDSCO Panel Approves Akums' Proposal to Manufacture, Market Nitisinone Dispersible Tablets for Hereditary Tyrosinemia Type 1

Susmita Roy30 Nov 2025 4:00 PM IST

New Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has recommended granting...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok